Literature DB >> 15121324

Control without separate controls: evaluation of vaccine safety using case-only methods.

C P Farrington1.   

Abstract

Epidemiological methods involving only cases are reviewed in the context of vaccine safety studies. These methods include some ecological methods, case-coverage methods, case-crossover and self-controlled case series methods. The properties of the methods are described using examples from the literature. It is argued that such methods, and in particular the self-controlled case series method, are powerful epidemiologic tools meriting the same attention as more traditional cohort and case-control methods.

Mesh:

Substances:

Year:  2004        PMID: 15121324     DOI: 10.1016/j.vaccine.2004.01.017

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Pharmacoepidemiology.

Authors:  Stephen J W Evans
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.

Authors:  Anthony Grosso; Ian Douglas; Aroon Hingorani; Raymond MacAllister; Liam Smeeth
Journal:  Br J Clin Pharmacol       Date:  2008-07-31       Impact factor: 4.335

3.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Authors:  Sharon K Greene; Martin Kulldorff; Edwin M Lewis; Rong Li; Ruihua Yin; Eric S Weintraub; Bruce H Fireman; Tracy A Lieu; James D Nordin; Jason M Glanz; Roger Baxter; Steven J Jacobsen; Karen R Broder; Grace M Lee
Journal:  Am J Epidemiol       Date:  2009-12-04       Impact factor: 4.897

4.  "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events.

Authors:  David Evans; Simon Cauchemez; Frederick G Hayden
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

5.  The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.

Authors:  Matthew F Daley; Christina L Clarke; Jason M Glanz; Stanley Xu; Simon J Hambidge; James G Donahue; James D Nordin; Nicola P Klein; Steven J Jacobsen; Allison L Naleway; Michael L Jackson; Grace Lee; Jonathan Duffy; Eric Weintraub
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-11-17       Impact factor: 2.890

6.  Future cases as present controls to adjust for exposure trend bias in case-only studies.

Authors:  Shirley Wang; Crystal Linkletter; Malcolm Maclure; David Dore; Vincent Mor; Stephen Buka; Gregory A Wellenius
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

7.  Quantitative Bias Analysis in Regulatory Settings.

Authors:  Timothy L Lash; Matthew P Fox; Darryl Cooney; Yun Lu; Richard A Forshee
Journal:  Am J Public Health       Date:  2016-05-19       Impact factor: 9.308

8.  Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.

Authors:  Julia Stowe; Nicholas Andrews; Christopher Kosky; Gary Dennis; Sofia Eriksson; Andrew Hall; Guy Leschziner; Paul Reading; John M Shneerson; Katherine Donegan; Elizabeth Miller
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

Review 9.  The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Authors:  Pier Luigi Lopalco; Frank DeStefano
Journal:  Vaccine       Date:  2014-11-04       Impact factor: 3.641

10.  The use of relative incidence ratios in self-controlled case series studies: an overview.

Authors:  Steven Hawken; Beth K Potter; Julian Little; Eric I Benchimol; Salah Mahmud; Robin Ducharme; Kumanan Wilson
Journal:  BMC Med Res Methodol       Date:  2016-09-23       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.